Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OrthoCarolina Research Achieves Landmark Success in Opioid-Free Surgical Recovery


News provided by

OrthoCarolina

May 08, 2025, 09:15 ET

Share this article

Share toX

Share this article

Share toX

OrthoCarolina Research Institute
OrthoCarolina Research Institute

Breakthrough research from the OrthoCarolina Research Institute sets new standard for pain management

CHARLOTTE, N.C., May 8, 2025 /PRNewswire-PRWeb/ -- The OrthoCarolina Research Institute (OCRI), the nonprofit research partner of OrthoCarolina, is celebrating the success of its pioneering and patient-inspired initiative to reduce opioid use in surgical recovery. The Carolinas Opioid Reduction Effort (CORE) program has shown significant success in providing patients with opioid-minimizing recovery options, dramatically reducing the risk of addiction, as well as improving recovery experiences.

The work behind CORE began in 2017 with a pilot study focused on opioid-free pain management in shoulder replacement surgeries. Building on those promising results, OCRI officially launched CORE in March 2018. Since then, OCRI has led the charge in transforming how orthopedic care is approached by offering patients a safe and effective alternative to opioids from the outset of their treatment. Backed by OrthoCarolina physician research, CORE is implementing proactive, prevention-focused strategies that empower patients to make informed decisions about their pain management, providing them with opioid-reducing options.CORE has not only improved individual patient outcomes but is also setting a new standard for the healthcare community at large, positioning it as a national model for reducing opioid use during and after orthopedic surgery.

"This is prevention at its core," said Christi Cadd, Executive Director of OrthoCarolina Research Institute. "By offering patients a safe and effective alternative to opioids before they're ever exposed, we're helping to break the cycle of addiction that can begin with a prescription."

Post this

"This is prevention at its core," said Christi Cadd, Executive Director of OrthoCarolina Research Institute. "By offering patients a safe and effective alternative to opioids before they're ever exposed, we're helping to break the cycle of addiction that can begin with a prescription."

The success of the program is evidenced by its groundbreaking research, partnered with AtriumHealth, Charlotte Surgery Center, Novant Health, and OrthoCarolina, which standardized non-opioid protocols for a year. Published in The Journal of Bone & Joint Surgery, one of the most prestigious peer-reviewed journals in the field, the study confirmed the clinical success of the program. Patients reported less pain, improved comfort, and fewer side effects compared to traditional opioid-based regimens.

Building on this momentum, The Duke Endowment has invested well over $1 million across three grants to help scale the program statewide. OCRI's next steps include:

  • Empower Patients: Educate patients about their pain management options by providing resources. By disseminating OCRI's findings through opioidreduction.com, their goal is to equip patients to have conversations with their care team about their medication preferences.
  • Change Practices: Reduce opioid prescriptions by educating physicians worldwide of our novel opioid free surgical research. Real-time data tracking shows that 52% of patients across OrthoCarolina have opted to reduce or eliminate opioids since November 2024.
  • Expand Access: OCRI is expanding this opioid-minimizing research through integration with Epic electronic medical records (EMR). Epic Systems is the most widely used EMR system globally. Next steps include education outreach and partnerships in more North Carolina communities, including those hardest hit by opioid addiction, such as Wilmington, Hickory, and Jacksonville.

"CORE exemplifies what makes OrthoCarolina different," said Dr. Leo Spector, CEO of OrthoCarolina. "It's as important to provide exceptional surgical care as it is to invest in research that shapes the future of medicine. Thanks to the dedication of our physicians and the support of partners like The Duke Endowment, we're creating solutions that protect our patients and strengthen our communities."

"Reducing opioid use in clinical settings is one of the most effective ways to address addiction at its source," said Stacy Warren, associate director of the Health Care program area at The Duke Endowment. "Through this grant, we were proud to support OrthoCarolina Research Institute's commitment to prevention, research, and community health."

With the expansion of CORE, OrthoCarolina and OCRI are setting a new standard for addressing opioid use in surgical recovery, not just within the practice but across the healthcare landscape. The program's success in providing opioid-minimizing recovery options has the potential to revolutionize pain management protocols, prevent opioid addiction before it starts, and ultimately save lives. As the largest physician-owned and led orthopedic practice in the Southeast, OrthoCarolina's continued investment in innovative research through OCRI ensures that it remains at the forefront of addressing one of the nation's most pressing public health crises. To learn more or donate to OCRI, visit www.orthocarolinaresearch.org.

About OrthoCarolina

Since 1922, OrthoCarolina has been a distinguished and reputable physician-owned and physician-led orthopedic practice that prioritizes delivering exceptional patient-centered care and pioneering solutions. An industry leader in orthopedic treatment, research, and education, they provide world-class musculoskeletal care across the Carolinas with 40+ locations and seven Orthopedic Urgent Care Centers. OrthoCarolina consistently pushes the boundaries of medical advancements and actively contributes to the training of new specialists, while working to enhance accessibility to unparalleled orthopedic care. Learn more at www.orthocarolina.com.

About OrthoCarolina Research Institute

The OrthoCarolina Research Institute (OCRI) is an independent nonprofit 501(c)(3) organization focused on advancing orthopedic care through research, education, and innovation. OCRI conducts a wide range of studies across orthopedic subspecialties, reshaping patient care for a healthier future in the Carolinas and beyond.. In partnership with OrthoCarolina physicians, universities, and industry leaders, OCRI shares their results across the world, leading to better medical care, better patient outcomes, and better cost efficiency. To learn more or donate to OCRI, visit www.orthocarolinaresearch.org.

Media Contact

Mae Young, OrthoCarolina, 1 704-218-9362, [email protected], https://www.orthocarolina.com/ 

SOURCE OrthoCarolina

Modal title

OrthoCarolina
OrthoCarolina
OrthoCarolina Research Institute
OrthoCarolina Research Institute
OrthoCarolina OrthoCarolina Research Institute

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.